Phase II Study of Anti-CD19 CAR-T Cells Treating Leukemia Children

Clinical trial NCT04325841 · COMPLETED

Trial details

NCT number: NCT04325841
Sponsor: Beijing Boren Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia, Pediatric Acute Lymphoblastic Leukemia, in Relapse Refractory Acute Lymphoblastic Leukemia

Start date: 2022-03-24
Primary completion: 2024-04-03
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.